TACC Antikörper und Ähnliche Produkte
Santa Cruz Biotechnology bietet eine umfassende Sammlung von TACC-Antikörpern für die fortgeschrittene Forschung in der Zellbiologie. TACC-Antikörper sind mit verschiedenen Techniken kompatibel, darunter Western Blotting (WB), Immunpräzipitation (IP), Immunfluoreszenz (IF), Immunhistochemie mit Paraffineinbettungen (IHCP), Durchflusszytometrie (FCM) und Enzymimmunoassay (ELISA). TACC-Proteine spielen eine entscheidende Rolle bei der Zellteilung und regulieren die Mikrotubuli-Dynamik, die für die korrekte Bildung der mitotischen Spindel unerlässlich ist. Eine Fehlregulierung von TACC-Proteinen wurde bei verschiedenen Krebsarten festgestellt, was sie zu wichtigen Zielen für therapeutische Maßnahmen und die Entdeckung von Biomarkern macht. Das Verständnis der Funktion von TACC-Proteinen bietet wertvolle Einblicke in die Tumorentstehung und mögliche Behandlungsstrategien. Forscher auf der ganzen Welt setzen monoklonale TACC-Antikörper ein, um zelluläre Mechanismen und Wege zu untersuchen, die an der Krebsentwicklung beteiligt sind. Fortschrittliche Forschungstechniken und -protokolle ermöglichen eine detaillierte Untersuchung der Expressionsmuster und Interaktionen von TACC-Proteinen. Die monoklonalen TACC-Antikörper von Santa Cruz Biotechnology unterstützen die wissenschaftliche Gemeinschaft dabei, die Krebsforschung und die therapeutische Entwicklung voranzutreiben.
Siehe auch...
Learn more about our ImmunoCruz® Antibody Conjugates and Cruz Marker™ MW Standards Promotional
TACC Antikörper
| Empty Table Header | Produkt | Katnr. | Isotyp | Epitop | Anwendungen | Species | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|---|
TACC1 Antikörper (E-3) | sc-377373 | mouse IgG1 κ | 47-85 (h) | WB, IP, IF, ELISA | m, r, h | neu | ||
TACC2 Antikörper (H-8) | sc-515342 | mouse IgG1 κ | 2294-2421 (h) | WB, IP, IF, ELISA | m, r, h | neu | ||
TACC3 Antikörper (C-2) | sc-376883 | mouse IgG1 κ | 45-83 (h) | WB, IP, IF, IHC(P), ELISA | m, r, h | 10 | ||
TACC3 Antikörper (D-2) | sc-48368 | mouse IgG1 κ | 1-300 (h) | WB, IP, IF, IHC(P), ELISA | m, r, h | 5 | ||
TACC3 Antikörper (E-4) | sc-376900 | mouse IgG2b κ | 45-83 (h) | WB, IP, IF, IHC(P), ELISA | m, r, h | 2 | ||
TACC3 Antikörper (C-5) | sc-271165 | mouse IgG2a κ | 19-41 (h) | WB, IP, IF, IHC(P), ELISA | m, r, h | neu | ||
TACC3 Antikörper (F-11) | sc-376839 | mouse IgG1 κ | 45-83 (h) | WB, IP, IF, ELISA | m, r, h | neu |
TACC CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
TACC1 CRISPR/Cas9 KO Plasmid (h) | sc-405285 | h | Gene Knockout | GFP | 0 | ||
TACC1 HDR Plasmid (h) | sc-405285-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
TACC1 Double Nickase Plasmid (h) | sc-405285-NIC | h | Gene Knockout | Puromycin | 0 | ||
TACC1 Double Nickase Plasmid (h2) | sc-405285-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
TACC1 CRISPR/Cas9 KO Plasmid (m) | sc-435727 | m | Gene Knockout | GFP | 0 | ||
TACC1 HDR Plasmid (m) | sc-435727-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
TACC1 Double Nickase Plasmid (m) | sc-435727-NIC | m | Gene Knockout | Puromycin | 0 | ||
TACC1 Double Nickase Plasmid (m2) | sc-435727-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
TACC2 CRISPR/Cas9 KO Plasmid (h2) | sc-405864-KO-2 | h | Gene Knockout | GFP | 1 | ||
TACC2 HDR Plasmid (h2) | sc-405864-HDR-2 | h | Homology Directed Repair | Puromycin | 1 | ||
TACC2 Double Nickase Plasmid (h) | sc-405864-NIC | h | Gene Knockout | Puromycin | 1 | ||
TACC2 Double Nickase Plasmid (h2) | sc-405864-NIC-2 | h | Gene Knockout | Puromycin | 1 | ||
TACC2 CRISPR/Cas9 KO Plasmid (m) | sc-425426 | m | Gene Knockout | GFP | 0 | ||
TACC2 HDR Plasmid (m) | sc-425426-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
TACC2 Double Nickase Plasmid (m) | sc-425426-NIC | m | Gene Knockout | Puromycin | 0 | ||
TACC2 Double Nickase Plasmid (m2) | sc-425426-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
TACC3 CRISPR/Cas9 KO Plasmid (h) | sc-402461 | h | Gene Knockout | GFP | 0 | ||
TACC3 HDR Plasmid (h) | sc-402461-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
TACC3 Double Nickase Plasmid (h) | sc-402461-NIC | h | Gene Knockout | Puromycin | 0 | ||
TACC3 Double Nickase Plasmid (h2) | sc-402461-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
TACC3 CRISPR/Cas9 KO Plasmid (m) | sc-423251 | m | Gene Knockout | GFP | 0 | ||
TACC3 HDR Plasmid (m) | sc-423251-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
TACC3 Double Nickase Plasmid (m) | sc-423251-NIC | m | Gene Knockout | Puromycin | 0 | ||
TACC3 Double Nickase Plasmid (m2) | sc-423251-NIC-2 | m | Gene Knockout | Puromycin | 0 |
TACC CRISPR Activation Products
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
TACC1 CRISPR Activation Plasmid (h) | sc-405285-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
TACC1 CRISPR Activation Plasmid (h2) | sc-405285-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
TACC1 Lentiviral Activation Particles (h) | sc-405285-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
TACC1 Lentiviral Activation Particles (h2) | sc-405285-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
TACC1 CRISPR Activation Plasmid (m) | sc-435727-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
TACC1 CRISPR Activation Plasmid (m2) | sc-435727-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
TACC1 Lentiviral Activation Particles (m) | sc-435727-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
TACC1 Lentiviral Activation Particles (m2) | sc-435727-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
TACC2 CRISPR Activation Plasmid (h) | sc-405864-ACT | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
TACC2 CRISPR Activation Plasmid (h2) | sc-405864-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
TACC2 Lentiviral Activation Particles (h) | sc-405864-LAC | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
TACC2 Lentiviral Activation Particles (h2) | sc-405864-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
TACC2 CRISPR Activation Plasmid (m) | sc-425426-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
TACC2 CRISPR Activation Plasmid (m2) | sc-425426-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
TACC2 Lentiviral Activation Particles (m) | sc-425426-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
TACC2 Lentiviral Activation Particles (m2) | sc-425426-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
TACC3 CRISPR Activation Plasmid (h) | sc-402461-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
TACC3 CRISPR Activation Plasmid (h2) | sc-402461-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
TACC3 Lentiviral Activation Particles (h) | sc-402461-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
TACC3 Lentiviral Activation Particles (h2) | sc-402461-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
TACC3 CRISPR Activation Plasmid (m) | sc-423251-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
TACC3 CRISPR Activation Plasmid (m2) | sc-423251-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
TACC3 Lentiviral Activation Particles (m) | sc-423251-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
TACC3 Lentiviral Activation Particles (m2) | sc-423251-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |
TACC siRNA, shRNA Plasmid and shRNA Lentiviral Particle Gene Silencers
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
TACC1 siRNA (h) | sc-37499 | h | Gene Silencing | N/A | 0 | ||
TACC1 shRNA Plasmid (h) | sc-37499-SH | h | Gene Silencing | Puromycin | 0 | ||
TACC1 shRNA (h) Lentivirale Partikel | sc-37499-V | h | Gene Silencing | Puromycin | 0 | ||
TACC1 siRNA (m) | sc-154042 | m | Gene Silencing | N/A | 0 | ||
TACC1 shRNA Plasmid (m) | sc-154042-SH | m | Gene Silencing | Puromycin | 0 | ||
TACC1 shRNA (m) Lentivirale Partikel | sc-154042-V | m | Gene Silencing | Puromycin | 0 | ||
TACC2 siRNA (h) | sc-37500 | h | Gene Silencing | N/A | 0 | ||
TACC2 shRNA Plasmid (h) | sc-37500-SH | h | Gene Silencing | Puromycin | 0 | ||
TACC2 shRNA (h) Lentivirale Partikel | sc-37500-V | h | Gene Silencing | Puromycin | 0 | ||
TACC2 siRNA (m) | sc-37501 | m | Gene Silencing | N/A | 0 | ||
TACC2 shRNA Plasmid (m) | sc-37501-SH | m | Gene Silencing | Puromycin | 0 | ||
TACC2 shRNA (m) Lentivirale Partikel | sc-37501-V | m | Gene Silencing | Puromycin | 0 | ||
TACC3 siRNA (h) | sc-36602 | h | Gene Silencing | N/A | 2 | ||
TACC3 shRNA Plasmid (h) | sc-36602-SH | h | Gene Silencing | Puromycin | 2 | ||
TACC3 shRNA (h) Lentivirale Partikel | sc-36602-V | h | Gene Silencing | Puromycin | 2 | ||
TACC3 siRNA (m) | sc-36603 | m | Gene Silencing | N/A | 0 | ||
TACC3 shRNA Plasmid (m) | sc-36603-SH | m | Gene Silencing | Puromycin | 0 | ||
TACC3 shRNA (m) Lentivirale Partikel | sc-36603-V | m | Gene Silencing | Puromycin | 0 |